Aclaris Therapeutics, Inc.

ACRS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $254.6M

Liabilities Breakdown FY2022

Total Liabilities: $57.0M